News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

January 8, 2026

WATCH: Drs. Jen Specht and Heather Racine discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer

January 8, 2026

AI models advance individualized breast cancer recurrence risk assessments

January 8, 2026

Caris, cooperative groups advancing AI models that can improve breast cancer risk assessments (access requires free registration)

January 8, 2026

WATCH: Dr. Joe Sparano discusses a new AI tool for breast cancer recurrence screening

December 22, 2025

The December 2025 News from ECOG-ACRIN blog is now available

December 22, 2025

WATCH: Dr. Joe Sparano talks with LinkedIn News about using AI for predicting breast cancer recurrence

December 11, 2025

Press Release: An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

December 10, 2025

Press Release: ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

December 3, 2025

NIH implements “zero-embargo” revisions to its public access policy for published scientific research

December 3, 2025

37 Member Networks and Programs Receive Commendations in 2025 for Research Performance

November 21, 2025

The November 2025 News from ECOG-ACRIN blog is now available

November 20, 2025

Guide to SABCS 2025: ECOG-ACRIN research at the world’s largest breast cancer conference

November 18, 2025

Guide to ASH 2025: ECOG-ACRIN and PrECOG are set to reveal multiple blood cancer research discoveries

November 4, 2025

The Fall 2025 advocacy blog, Considering Clinical Trials, is now available

November 3, 2025

STAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit

October 30, 2025

WATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival

October 20, 2025

Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

October 17, 2025

The October 2025 News from ECOG-ACRIN blog is now available

October 13, 2025

Now Enrolling: STOPGAP II trial opens for patients with stomach cancer

October 13, 2025

Institution Spotlight: Delaware/ChristianaCare NCORP

 
ECOG-ACRIN Cancer Research Group